Christian Bernard Matthijs Poulie

Christian Bernard Matthijs Poulie

Guest Researcher


  1. 2023
  2. Published

    Next generation fibroblast activation protein (FAP) targeting PET tracers : The tetrazine ligation allows an easy and convenient way to 18F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines

    Poulie, Christian Bernard Matthijs, Shalgunov, Vladimir, Elvas, F., Van Rymenant, Y., Moon, E. S., Battisti, Umberto Maria, De Loose, J., De Meester, I., Rösch, F., Van Der Veken, P. & Herth, Matthias Manfred, 2023, In: European Journal of Medicinal Chemistry. 262, 10 p., 115862.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2024
  4. Published

    Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model

    Bohrmann, L., Poulie, Christian Bernard Matthijs, Rodríguez-Rodríguez, C., Karagiozov, S., Saatchi, K., Herth, Matthias Manfred & Häfeli, U. O., 2024, In: PLoS ONE. 19, 4, 18 p., e0300466.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Development and Preclinical Evaluation of [211At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer.

    El Fakiri, M., Ayada, N., Müller, Marius, Hvass, Lars, Gamzov, T. H., Clausen, Anne Skovsbo, Geis, N. M., Steinacker, N., Hansson, E., Lindegren, S., Aneheim, E., Jensen, H., Eder, A., Jensen, Andreas, Poulie, Christian Bernard Matthijs, Kjær, Andreas, Eder, M. & Herth, Matthias Manfred, 2024, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 65, 4, p. 593-599

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 43877477